Purchase Order 75N90025P00572
Award Date
7/15/25
Potential Completion Date
7/14/26
Potential Value
$15K
Federal Agency
NIH Clinical Center
Awardee
Cerus Corporation
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The contract, valued at $14,924.64, is for the provision of INTERCEPT Blood System equipment, illuminator maintenance services, and specialized pathogen reduction technology products. The contract has a performance period ending on June 7, 2025. Cerus...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cerus Corporation, a biomedical products company that specializes in blood safety technologies and pathogen reduction systems. The contract, valued at $45,898.00, is for the maintenance and support of INTERCEPT Blood System illuminators, which are essential components of Cerus's proprietary pathogen reduction process for blood products. The contract has an ultimate completion date of September 26, 2027. Cerus...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The contract is for the service and maintenance of the Cerus INTERCEPT Illuminator, which is a key component of the company's proprietary INTERCEPT Blood System. The INTERCEPT system uses riboflavin and ultraviolet light to inactivate pathogens in blood components, including platelets, plasma, and red blood cells,...
This is a firm-fixed price purchase order awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, to Cerus Corporation, a biomedical company specializing in blood safety technologies and pathogen reduction systems. The $82,389 contract is for the supply of INTERCEPT Illuminator 60 Hz systems and associated maintenance services. The illuminators are essential components of Cerus Corporation's proprietary INTERCEPT Blood System,...
Cerus Corporation was awarded a firm fixed price purchase order by the Defense Health Agency for $66,388 to provide service maintenance for two Cerus INTERCEPT Illuminators over a five year period from September 2019 through September 2024. The INTERCEPT Illuminators are pathogen reduction systems owned by the Naval Medical Center San Diego that use ultraviolet light and chemicals to inactivate pathogens in blood platelets. Cerus Corporation will provide all necessary services, materials, and...
This is a $133,640.00 firm fixed price purchase order awarded by the Defense Health Agency to Cerus Corporation, a small business manufacturer of biomedical products. The contract is for the provision of illuminator equipment and related maintenance services, with a completion date of October 24, 2019. Cerus has received over 20 previous federal contracts from agencies including the Department of Defense, Department of Veterans Affairs, and Department of Health and Human Services to provide...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cerus Corporation, a for-profit manufacturer of the INTERCEPT Blood System, a pathogen reduction technology for platelets and plasma. The $369,384 contract is for the supply of INTERCEPT Platelet Processing Sets, Dual Storage Containers, and maintenance services for INTERCEPT Blood System illuminators to support medical readiness and blood product safety at military healthcare facilities. The contract has...
This firm fixed price purchase order was awarded by the Defense Health Agency to Cerus Corporation for annual preventative maintenance of Intercept Illuminators located at Portsmouth, Virginia. Valued at $66,388, the contract includes a base year and four option years of maintenance and support for illuminators used to treat blood products. The sole source justification indicates the equipment requires specialized maintenance that can only be performed by the original equipment manufacturer....
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The contract, valued at $146,200.00, is for the procurement of INTERCEPT Blood System processing sets for dual storage. The INTERCEPT system uses riboflavin and ultraviolet light to inactivate pathogens in blood components such as platelets and plasma, enhancing blood safety. Cerus has a history of supplying its...
The National Institutes of Health (NIH) awarded a $28,924.80 firm fixed price purchase order contract to Cerus Corporation for the delivery of INTERCEPT Platelet Processing Sets with Dual Storage Containers. This sole-source contract is for the Department of Transfusion Medicine and will run from April 1, 2025 to September 30, 2025. Cerus Corporation's proprietary INTERCEPT technology is used to reduce the potential for virus replication in platelets, ensuring the safety of transfused blood...